Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis

被引：7

作者：

Gao, Xue-min ^{[1
,2
]}

Li, Jian ^{[1
,2
]}

Cao, Xin-xin ^{[1
,2
]}

机构：

[1] Peking Union Med Coll Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Dept Hematol, Beijing, Peoples R China

[2] Peking Union Med Coll Hosp, Chinese Acad Med Sci, Peking Union Med Coll, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China

来源：

CELL COMMUNICATION AND SIGNALING | 2022年 / 20卷 / 01期

基金：

北京市自然科学基金;

关键词：

Langerhans cell histiocytosis (LCH); MAPK pathway; Inflammatory myeloid malignancy; Progenitor cells; RAF inhibitors; MEK inhibitors; ERDHEIM-CHESTER DISEASE; DENDRITIC CELL; T-CELLS; ABUNDANT EXPRESSION; HIGH PREVALENCE; BRAF MUTATIONS; VEMURAFENIB; LCH; INHIBITION; MAP2K1;

D O I：

10.1186/s12964-022-00917-0

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Langerhans cell histiocytosis (LCH) is an inflammatory myeloid malignancy in the "L-group " histiocytosis. Mitogen-activated protein kinase (MAPK) pathway activating mutations are detectable in nearly all LCH lesions. However, the pathogenic roles of MAPK pathway activation in the development of histiocytosis are still elusive. This review will summarize research concerning the landscape and pathogenic roles of MAPK pathway mutations and related treatment opportunities in Langerhans cell histiocytosis.

引用

页数：16

共 50 条

[31] Langerhans cell histiocytosis
Joan Manel Gasent Blesa
Vicente Alberola Candel
Carlos Solano Vercet
Juan Laforga Canales
Christof Semler
M. Rosa Pérez Antolí
Carlos Rodríguez-Galindo
Clinical and Translational Oncology, 2008, 10 : 688 - 696
[32] Langerhans cell histiocytosis
Margo, Curtis E.
Goldman, Darin R.
SURVEY OF OPHTHALMOLOGY, 2008, 53 (04) : 332 - 358
[33] Langerhans'-Cell Histiocytosis
Mehta, Bhakti
Venkatramani, Rajkumar
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11): : 1050 - 1050
[34] LANGERHANS CELL HISTIOCYTOSIS
HEFTI, F
JUNDT, G
ORTHOPADE, 1995, 24 (01): : 73 - 81
[35] LANGERHANS CELL HISTIOCYTOSIS
BELAICH, S
DERMATOLOGY, 1994, 189 : 2 - 7
[36] Langerhans cell histiocytosis
Blesa, Joan Manel Gasent
Candel, Vicente Alberola
Vercet, Carlos Solano
Laforga Canales, Juan
Semler, Christof
Perez Antoli, M. Rosa
Rodriguez-Galindo, Carlos
CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (11): : 688 - 696
[37] Langerhans cell histiocytosis
Greenhill, Mark
Schafernak, Kristian
Schaefer, Carrie
Kaye, Robin
Aria, David
Abruzzo, Todd
Towbin, Alex
Towbin, Richard
APPLIED RADIOLOGY, 2019, 48 (03) : 39 - 41
[38] Langerhans cell histiocytosis
Kumar, Manish
Menon, Anil S.
INDIAN JOURNAL OF MEDICAL RESEARCH, 2018, 148 (03) : 351 - 352
[39] Langerhans cell histiocytosis
Caldemeyer, KS
Parks, ET
Mirowski, G
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (03) : 509 - 511
[40] LANGERHANS CELL HISTIOCYTOSIS
EGELER, RM
DANGIO, GJ
JOURNAL OF PEDIATRICS, 1995, 127 (01): : 1 - 11

← 1 2 3 4 5 →